TIMI 9 Registry assessed management strategies and outcomes of patients presenting with ST elevation myocardial infarction in the era of aggressive reperfusion strategies, who were ineligible for fibrinolytic therapy.
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry
Crit Pathw Cardiol. 2002 Mar;1(1):44-52.
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003 Jan;145(1):109-17.